SCHEMBL7867792

SCHEMBL7867792

CCCCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(OC(=O)NCCO)nc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.49
SMPD1 P17405 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
NAAA Q02083 2/20 0.42
EGFR P00533 2/20 0.42
MGLL Q99685 1/20 0.41
MLYCD O95822 1/20 0.40
GABRA5 P31644 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
P4HTM Q9NXG6 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870566 0.96 EGFR (0.43) CA2SMPD1EGFRGABRA5P4HTM
SCHEMBL7862801 0.92 CA2 (0.48) CA2L3MBTL1NAAAEGFRMGLL
SCHEMBL7869413 0.90 SMPD1 (0.45) CA2SMPD1NAAAGABRA5
SCHEMBL7871556 0.90 CA2 (0.47) CA2L3MBTL1NAAAEGFRMGLL
SCHEMBL7871681 0.89 EGFR (0.46) CA2EGFRGABRA5P4HTMCA12
SCHEMBL7870463 0.89 KMT2A (0.46) L3MBTL1EGFRP4HTM
SCHEMBL7871651 0.89 BCL2L1 (0.46) EGFRP4HTM
SCHEMBL7869442 0.88 EGFR (0.43) CA2L3MBTL1EGFRGABRA5P4HTM
SCHEMBL9574879 0.88 NPC1 (0.52) CA2CA12CA1CA9CA14
SCHEMBL9018027 0.88 CA2 (0.52) CA2L3MBTL1NAAAEGFRMLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed